In summary, we demonstrated that APOE4 increases the risk of AD-tau pathology, but not AGD-tau pathology, accompanied with exacerbated accumulation of insoluble Aβ40, Aβ42, apoE and pTau181. This evidence concerns the gene MAPT and Alzheimer disease.